Fri, 24 Apr 2020 04:54:19 GMT
Eli Lilly posts 15% surge in Q1 sales
Eli Lilly posted a 15.1% surge in its Q1 sales, driven by robust sales of Trulicity, the firm's top-selling diabetes drug, and growing demand for other medicines amid the coronavirus outbreak.